{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:40:29Z","timestamp":1791852029135,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Public Health Service","award":["R01AI092129"],"award-info":[{"award-number":["R01AI092129"]}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Allergy and Infectious Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Manchot foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.vaccine.2017.03.070","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T10:22:19Z","timestamp":1491214939000},"page":"2543-2549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge"],"prefix":"10.1016","volume":"35","author":[{"given":"Sukumar","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Favaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia F.","family":"Tifrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp T.","family":"Hanisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren E.T.","family":"Luczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H.","family":"Hegemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"de la Maza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.070_b0005","unstructured":"Centers for Disease Control and Prevention C. 2015 Sexually Transmitted Diseases Treatment Guidelines. Sexually transmitted diseases; 2015. <http:\/\/www.cdc.gov\/std\/tg2015\/chlamydia.htm>."},{"key":"10.1016\/j.vaccine.2017.03.070_b0010","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/jama.291.18.2229","article-title":"Prevalence of chlamydial and gonococcal infections among young adults in the United States","volume":"291","author":"Miller","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.03.070_b0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.olq.0000187205.67390.d1","article-title":"Prediction of pelvic inflammatory disease among young, single, sexually active women","volume":"33","author":"Ness","year":"2006","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2017.03.070_b0020","unstructured":"Stamm W. Chlamydia trachomatis infections of the adult. In: KK Holmes PS, Stamm WE, Piot P, Wasserheit JW, Corey L, Cohen MS, et al., editor. Sex Transm Dis. New York: McGrawHill Book Co.; 2008. p. 575\u201393."},{"key":"10.1016\/j.vaccine.2017.03.070_b0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.spid.2005.06.004","article-title":"Chlamydia trachomatis infections in neonates and young children","volume":"16","author":"Darville","year":"2005","journal-title":"Semin Pediatr Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2017.03.070_b0030","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0002-9394(67)94130-X","article-title":"A potency test for trachoma vaccine utilizing the mouse toxicity prevention test","volume":"63","author":"Wang","year":"1967","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0035","series-title":"Human chlamydial infections","author":"Schachter","year":"1978"},{"key":"10.1016\/j.vaccine.2017.03.070_b0040","series-title":"Trachoma: a blinding scourge from the Bronze Age to the twenty-first century","author":"Taylor","year":"2008"},{"key":"10.1016\/j.vaccine.2017.03.070_b0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/infdis\/163.2.233","article-title":"Cofactors in male-female sexual transmission of Human Immunodeficiency Virus type 1","volume":"163","author":"Plummer","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.070_b0050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00404-013-3122-3","article-title":"Chlamydia trachomatis infection: implications for HPV status and cervical cancer","volume":"289","author":"Silva","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.vaccine.2017.03.070_b0055","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1086\/497341","article-title":"The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection","volume":"192","author":"Brunham","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.070_b0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/00365540110077001","article-title":"Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods?","volume":"34","author":"Gotz","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.070_b0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0264-410X(95)80022-6","article-title":"A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections","volume":"13","author":"de la Maza","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.070_b0070","first-page":"980","article-title":"Vaccines for Chlamydia trachomatis infections","volume":"3","author":"de la Maza","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.vaccine.2017.03.070_b0075","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1586\/erv.09.98","article-title":"Chlamydia vaccine candidates and tools for chlamydial antigen discovery","volume":"8","author":"Rockey","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.03.070_b0080","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.00881-10","article-title":"Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model","volume":"79","author":"Farris","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.070_b0085","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1016\/j.vaccine.2011.05.013","article-title":"Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine","volume":"29","author":"Carmichael","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.070_b0090","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1128\/IAI.73.12.8153-8160.2005","article-title":"Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria","volume":"73","author":"Pal","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.070_b0095","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1016\/j.vaccine.2009.05.008","article-title":"Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.070_b0100","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.4049\/jimmunol.0804375","article-title":"Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine","volume":"182","author":"Kari","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0105","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.4049\/jimmunol.1303392","article-title":"Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum","volume":"192","author":"Tifrea","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jprot.2012.08.017","article-title":"Proteomic identification of immunodominant chlamydial antigens in a mouse model","volume":"77","author":"Teng","year":"2012","journal-title":"J Proteomics"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2017.03.070_b0115","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/0002-9394(67)94155-4","article-title":"Trachoma vaccine studies in monkeys","volume":"63","author":"Wang","year":"1967","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0120","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1016\/j.vaccine.2011.04.065","article-title":"Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccine","volume":"29","author":"Tifrea","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.070_b0125","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.282.5389.754","article-title":"Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis","volume":"282","author":"Stephens","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.03.070_b0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/omi.1.1999.4.187","article-title":"Computational analysis of the polymorphic membrane protein superfamily of Chlamydia trachomatis and Chlamydia pneumoniae","volume":"4","author":"Grimwood","year":"1999","journal-title":"Microb Comp Genom"},{"key":"10.1016\/j.vaccine.2017.03.070_b0135","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1462-5822.2009.01389.x","article-title":"Variable expression of surface-exposed polymorphic membrane proteins in in vitro-grown Chlamydia trachomatis","volume":"12","author":"Tan","year":"2010","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0140","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1462-5822.2011.01598.x","article-title":"Altered developmental expression of polymorphic membrane proteins in penicillin-stressed Chlamydia trachomatis","volume":"13","author":"Carrasco","year":"2011","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0145","doi-asserted-by":"crossref","first-page":"e878","DOI":"10.1371\/journal.pone.0000878","article-title":"Comparative expression profiling of the Chlamydia trachomatis pmp gene family for clinical and reference strains","volume":"2","author":"Nunes","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.03.070_b0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000447092","article-title":"The number, organization, and size of polymorphic membrane protein coding sequences as well as the most conserved Pmp protein differ within and across Chlamydia species","volume":"26","author":"Van Lent","year":"2016","journal-title":"J Mol Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/21505594.2015.1111509","article-title":"Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates","volume":"7","author":"Vasilevsky","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2017.03.070_b0160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0966-842X(01)02234-X","article-title":"Polymorphic proteins of Chlamydia spp.\u2013autotransporters beyond the Proteobacteria","volume":"9","author":"Henderson","year":"2001","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0165","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1073\/pnas.0508983103","article-title":"Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen","volume":"103","author":"Crane","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.03.070_b0170","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1371\/journal.pone.0000568","article-title":"Expression, processing, and localization of PmpD of Chlamydia trachomatis Serovar L2 during the chlamydial developmental cycle","volume":"2","author":"Kiselev","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.03.070_b0175","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1128\/IAI.01173-08","article-title":"Chlamydia trachomatis polymorphic membrane protein D is an oligomeric autotransporter with a higher-order structure","volume":"77","author":"Swanson","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.070_b0180","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/mbo3.186","article-title":"All subtypes of the Pmp adhesin family are implicated in chlamydial virulence and show species-specific function","volume":"3","author":"Becker","year":"2014","journal-title":"MicrobiologyOpen"},{"key":"10.1016\/j.vaccine.2017.03.070_b0185","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1365-2958.2010.07386.x","article-title":"Members of the Pmp protein family of Chlamydia pneumoniae mediate adhesion to human cells via short repetitive peptide motifs","volume":"78","author":"Molleken","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1574-6968.2001.tb10834.x","article-title":"Differential expression of Pmp10 in cell culture infected with Chlamydia pneumoniae CWL029","volume":"203","author":"Pedersen","year":"2001","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2017.03.070_b0195","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1128\/IAI.01566-08","article-title":"Chlamydia trachomatis-infected patients display variable antibody profiles against the nine-member polymorphic membrane protein family","volume":"77","author":"Tan","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.070_b0200","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4049\/jimmunol.1001240","article-title":"A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans","volume":"185","author":"Wang","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0205","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1128\/IAI.00626-10","article-title":"Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice","volume":"79","author":"Cruz-Fisher","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.070_b0210","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.4049\/jimmunol.180.4.2459","article-title":"Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia","volume":"180","author":"Karunakaran","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0215","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1128\/IAI.01374-09","volume":"78","author":"Yu","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.070_b0220","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/IAI.06338-11","article-title":"Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice","volume":"80","author":"Yu","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.070_b0225","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.182.3.1602","article-title":"Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models","volume":"182","author":"Yu","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0230","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1016\/j.vaccine.2014.06.002","article-title":"Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice","volume":"32","author":"Yu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.070_b0235","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.vaccine.2015.02.055","article-title":"Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine","volume":"33","author":"Karunakaran","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.070_b0240","doi-asserted-by":"crossref","first-page":"e0157875","DOI":"10.1371\/journal.pone.0157875","article-title":"A probiotic adjuvant Lactobacillus rhamnosus enhances specific immune responses after ocular mucosal immunization with chlamydial polymorphic membrane protein C","volume":"11","author":"Inic-Kanada","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.03.070_b0245","doi-asserted-by":"crossref","first-page":"e0144380","DOI":"10.1371\/journal.pone.0144380","article-title":"Delivery of a chlamydial adhesin N-PmpC subunit vaccine to the ocular mucosa using particulate carriers","volume":"10","author":"Inic-Kanada","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.03.070_b0250","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1365-2958.2011.07877.x","article-title":"Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms","volume":"82","author":"Saka","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0255","doi-asserted-by":"crossref","first-page":"989762","DOI":"10.1155\/2011\/989762","article-title":"The role of Chlamydia trachomatis polymorphic membrane proteins in inflammation and sequelae among women with pelvic inflammatory disease","volume":"2011","author":"Taylor","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.03.070_b0260","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1128\/JB.186.13.4295-4306.2004","article-title":"Recombination in the genome of Chlamydia trachomatis involving the polymorphic membrane protein C gene relative to ompA and evidence for horizontal gene transfer","volume":"186","author":"Gomes","year":"2004","journal-title":"J Bacteriol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17304048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17304048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T21:30:39Z","timestamp":1535923839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17304048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":52,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0264410X17304048"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}